Gen-AI is a massive tailwind for our business; expect to improve on industry growth rate of 12%: IKS Health Management

December 19, 2024

IKS Health, a healthcare platform serving 18% of US physicians, projects exceeding the industry’s 12% growth rate. They aim for 30%+ EBITDA margins within two years, driven by tech leverage and the AQuity acquisition. Confident in long-term growth, they emphasize a large total addressable market and the potential of generative AI.

More To Explore

Ventive Hospitality IPO subscribed 1.28 times as on Day 2. Check GMP, key dates and review

Ventive Hospitality IPO GMP: Ventive Hospitality’s Rs 1,600 crore IPO has been subscribed 78% by December 20, attracting strong demand from QIBs. The company offers

December 23, 2024

Gautam Duggad sees PE re-rating potential in 2 sectors; likes largecaps & may raise weight in Reliance

Gautam Duggal, Head of Research at Motilal Oswal, sees limited PE re-rating potential, primarily in large-cap financials and capital market stocks. He favors earnings visibility

December 23, 2024

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003